Patents by Inventor Sharon L. Wannberg

Sharon L. Wannberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Endothelial cell derived hematopoietic growth factor
    Publication number: 20030124091
    Abstract: The present invention relates to human and porcine endothelial cell derived growth factors (EDHF) that contain one or a mixture of more than one endothelial cell proteins having a molecular weight greater than about 30 kDa. The EDHF is added to culture medium to expand tri-lineage pre-dendritic myleomonocytic progenitor cells and culture endothelial cells. The present invention also relates to a method of amplifying myeloid dendritic cell precursors both in vitro and in vivo. The EDHF is also used therapeutically to increase myeloid dendritic cell production in vivo to enhance the activity of vaccines.
    Type: Application
    Filed: October 25, 2002
    Publication date: July 3, 2003
    Applicant: Large Scale Biology Corporation
    Inventors: Daniel Tuse, Thomas A. Davis, Alison A. McCormick, Sharon L. Wannberg